Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Umbilical Cord Blood for Autism Spectrum Disorder
NCT04768816Phase 1Unknown
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Jul 2019
- Primary completion
- Dec 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of autologous umbilical cord blood in Autism Spectrum Disorder (ASD), sponsored by Guangdong Women and Children Hospital. Primary endpoints: Autism Behavior Checklist at 24 months and Childhood Autism Rating Scale at 24 months. Status: unknown.
02
Drugs
autologous umbilical cord blood
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04768816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04768816.